What Are the Benefits of Microdosing? | Goop
Numinus's VP of Psychedelic Neurology, Dr. Evan Lewis, chats with Kelly Martin from Goop to discu
Read More
Numinus Files U.S. Provisional Patent Application for a Proprietary Rapid Production Process for Psilocybe and Other Psychoactive Fungi Species
Process leads to standardized psychedelic extracts that are reproducible, scalable, cost-effective a
Read More
Experts favour use of magic mushroom derivatives for research into mental health treatment
Educators, researchers see value in studying psilocybin’s effect treating mental health and addict
Read More
The business of producing psychedelics for science
The Daily Hive's Peter Smith speaks to Numinus CEO, Payton Nyquvest, about the business side of psyc
Read More
Numinus licensed by Health Canada to extract and research psilocybin
Numinus CEO, Payton Nyquvest, and Chief Operating Officer, Michael Tan, spoke to Mugglehead about an
Read More
Numinus Licencing Amendment: We Speak to the Team
Numinus Chief Operating Officer Michael Tan explains what the company's recent Health Canada licence
Read More
